FDA Adverse Event Injury Summary report: N

PALMAZ GENESIS AMIIA

MDR report key: 1074496 · Received July 10, 2008

Doing adverse event research by hand?

The Research Assistant searches MAUDE for you, groups reports by failure mode, and cites every record.

Free to try · every answer cites its records

Report

Report Number
9610978-2008-00177
Event Type
Injury
Date Received
July 10, 2008
Date of Event
June 12, 2008
Report Date
June 16, 2008
Manufacturer
CORDIS EUROPA, N.V.
Product Code
FGE
PMA / PMN Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A DEVICE HISTORY RECORD REVIEW WAS PERFORMED AND SHOWED THAT THIS LOT OF PRODS MET ALL REQUIREMENTS PER THE APPLICABLE MFG QUAL PLAN (MQP). THIS REVIEW WAS EXTENDED TO SUBASSEMBLY AND THE REVIEW CONFIRMED THAT SUBASSEMBLIES MET ALL REQUIREMENTS PER THE APPLICABLE MQP AS WELL, INCLUDING THE BURST TEST VALUES. THE STENT DELIVERY SYSTEM (SDS) HAD BEEN RETURNED FOR EVAL AND TESTING, HOWEVER THE FAILURE ANALYSIS REPORT IS NOT COMPLETE. ADD'L INFO WILL BE SENT WITHIN 30 DAYS UPON RECEIPT.

Description of Event or Problem · 1

REPORT REC'D INDICATED BALLOON RUPTURED DURING INFLATION. THE INTENDED TARGET LESION WAS THE LEFT RENAL ARTERY. THE LESION HAD 90% STENOSIS. IS NOT KNOWN IF THE LESION WAS PREDILATED AND NO OTHER VESSEL/LESION CHARACTERISTICS WERE AVAILABLE. THE STENT DELIVERY SYS (SDS) WAS ADVANCED TOWARDS THE LESION WITHOUT AND ANOMALIES REPORTED AND THE BALLOON WAS INFLATED AT THE LESION SITE. HOWEVER, THE BALLOON RUPTURED DURING ITS INFLATION AT UNK ATMOSPHERES. THE STENT WAS NOT FULLY DEPLOYED. THEREFORE, THE SDS WAS RETRIEVED AND ANOTHER BALLOON CATHETER WAS USED TO DEPLOY THE STENT SUCCESSFULLY. POST STENT DEPLOYMENT SHOWED EXCELLENT VESSEL BLOOD FLOW AND NO ADVERSE CONSEQUENCE TO THE PT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PALMAZ GENESIS AMIIA ENDOVASCULAR SDS/STENTS (FGE) FGE CORDIS EUROPA, N.V. NA R0807231

Patients

Seq Age Sex Outcome Treatment
1 69 YR Required Intervention